I-Infliximab ivele njengokwelashwa ngegazi kwezimo ezivuvukalayo ngemuva kokugunyazwa kwayo. Le biological TNF-α-inhibiting monoclonal antibody ithuthukisa futhi ithuthukise izivikeli mzimba, ukuletha impumuzo ezigulini ezinokuphazamiseka kokuvuvukala okumaphakathi kuya kokunzima.
Umuthi we-Infliximab ubonakale uphumelela ekwelapheni izimo eziningi. Umuthi usiza abantu abadala kanye neziguli zezingane nge Isifo sikaCrohn, izilonda emathunjini, rheumatoid arthritis (kuhlanganiswe ne-methotrexate), i-ankylosing spondylitis, i-psoriatic arthritis, ne-plaque psoriasis.
Lesi sihloko sinikeza ukuqonda okuningiliziwe kokusetshenziswa kwe-infliximab, umthamo, imiphumela engemihle engaba khona, nakho konke okudingeka ukucabange lapho usebenzisa lo muthi onamandla.
I-Infliximab ingeyekilasi lemithi elwa namagciwane eguqula izifo (bDMARDs). Umuthi unamathela ku-TNF-alpha futhi unciphise umsebenzi wawo ukuze unciphise ukuvuvukala kwezicubu ezithintekayo.
Umuthi uphatha izimo eziningana ze-autoimmune ngokuvuvukala:
Odokotela banikeza i-infliximab ngokufakwa emthanjeni okuthatha okungenani amahora ama-2. Ukwelashwa kuqala ngemithamo yokungeniswa emavikini angu-0, 2, no-6. Imithamo yesondlo ilandela njalo emavikini angu-8, ngaphandle kwe-ankylosing spondylitis, edinga imithamo njalo emavikini angu-6. Isimo sakho sinquma umthamo.
Imiphumela emibi evamile yilezi:
Imiphumela emibi ihlanganisa:
I-TNF-alpha (i-tumor necrosis factor-alpha) iphrotheni ebangela ukuvuvukala ezimeni zazo zonke izinhlobo. I-Infliximab ikhomba futhi inamathisele kule phrotheni ukuze imise imiphumela yayo eyingozi. Umuthi ubophezela ku-TNF-alpha kuwo womabili amafomu antantayo mahhala nangamaseli, okubavimbela ukuthi baxhumane nama-receptors abo.
Imithi futhi:
Kufanele uqaphele ngokuhlanganisa i-infliximab nemithi ethile. Ukuqapha okwengeziwe kuyadingeka ikakhulukazi uma une:
Odokotela banikeza i-infliximab nge-IV, ethatha okungenani amahora ama-2. Uhlelo lokwelapha olujwayelekile luhlanganisa:
Umuthi udinga isiqandisi phakathi kuka-2-8°C kuze kufike isikhathi sokuwusebenzisa.
I-Infliximab kube inketho yokwelapha ebalulekile ezigulini ezinezimo ezivuvukalayo kusukela yavunywa. Lo muthi wezinto eziphilayo uvimba amaprotheni e-TNF-alpha futhi wehlise ukuvuvukala emzimbeni wonke. Iziguli ezinesifo sika-Crohn, i-ulcerative colitis, i-rheumatoid arthritis, nezinye izifo ze-autoimmune ziye zathola ukukhululeka okukhethekile ngalokhu kwelashwa.
I-Infliximab inikeza ithemba ezigulini ebezinezinketho ezilinganiselwe ngaphambilini. Umuthi usiza abantu abaningi ukuthi balawule izimpawu zabo futhi bathuthukise izinga lempilo yabo, nakuba idinga ukuphathwa ngokucophelela nokuqapha. Amathimba okunakekelwa kwezempilo ahlala eyinsiza engcono kakhulu yokunquma ukuthi lokhu kwelashwa kusifanela yini isimo esithile sesiguli.
Imithi iza nezingozi ezithile odokotela abaziqapha ngokucophelela. Umzimba wakho uba sengozini yokuthola izifo, ikakhulukazi sofuba kanye nezifo fungal. Ezinye iziguli zenze i-lymphoma nezinye izinhlobo zomdlavuza. Udokotela wakho uzohlola izici zakho zobungozi futhi alandelele impilo yakho njalo ukuze alawule lezi zingozi.
Imiphumela iyahlukahluka phakathi kweziguli. Abanye abantu bazizwa bengcono ezinsukwini ezingu-2-3 beqale ukwelashwa. Abanye bangase badinge kufika emavikini angu-6. Ucwaningo lubonisa ukuthi iningi leziguli ezine-ulcerative colitis zisabela emasontweni ayisishiyagalombili. Ukuphulukiswa okuphelele kwamathumbu ngokuvamile kudinga isikhathi esengeziwe.
Kufanele ushayele ngokushesha ukuze uthole enye i-aphoyintimenti. Umjovo olandelayo uzohlelwa ngemva kwamasonto amabili. Ungalokothi uzame ukulungisa umthamo ogejiwe ngokuthatha kabili.
Ayikho i-antidote ethile ekhona ye-infliximab overdose. Udinga usizo lwezokwelapha ngokushesha uma usola ukuthi kune-overdose. Abasebenzi bezokwelapha bazobheka ukusabela okubi futhi belaphe izimpawu zakho.
Akufanele uthathe i-infliximab uma une:
Umuthi ulandela uhlelo oluthile. Uzothola imithamo emasontweni 0, 2, kanye 6, bese imithamo yesondlo njalo emavikini angu-8. Isimo sakho sisiza udokotela wakho ukuthi anqume isikhathi esiqondile.
I-Infliximab isebenza njengokwelashwa kwesikhathi eside. Iziguli ezisabela kahle ngokuvamile ziqhubeka nemithamo yesondlo njalo emavikini angu-8. Udokotela wakho uhlola njalo ukuze abone ukuthi kufanele yini uqhubeke nokwelapha.
Kungase kudingeke ukuthi uyeke ukuthatha i-infliximab uma:
I-Infliximab ayenzelwe ukusetshenziswa nsuku zonke. Umuthi usebenza ohlelweni oluthile oluqala ngemithamo emasontweni angu-0, 2, no-6. Ukufakwa kwesondlo kulandela njalo emavikini angu-6-8 ngokusekelwe esimweni sakho. Ukuyithatha nsuku zonke kungakhuphula imiphumela emibi kakhulu ngaphandle kwezinzuzo ezengeziwe.
Ishejuli yesikhungo sakho sezempilo inquma isikhathi njengoba i-infliximab idinga ukuphathwa ngomthambo endaweni yomtholampilo amahora angu-2+. Iziguli eziningi zithola ama-aphoyintimenti ekuseni esebenza kangcono kakhulu. Abasebenzi bezokwelapha bangaqapha noma yikuphi ukusabela okusheshayo usuku lonke.
Hlala kude ne-:
Ukushintsha kwesisindo akuyona imiphumela emibi evamile. Noma kunjalo, ezinye iziguli zibona ukushintshashintsha kwesisindo. Ukudla okulinganiselayo nokuzivocavoca okuvamile kuhlala kubalulekile ngesikhathi sokwelashwa.
Ukudla kwakho akudingi imikhawulo ethile. Kodwa-ke, kufanele uvikele amasosha akho omzimba ngokugwema: